Annual report
6197.TEDINET S100W2MF
Period2024-04-01 → 2025-03-31
Filed2025-06-24
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 155
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥137.4bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales |
| Revenue | ¥135.1bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales |
| Revenue | ¥131.1bn | 2022-04-01 → 2023-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥117.2bn | 2021-04-01 → 2022-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥106.2bn | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥7.0bn | 2024-04-01 → 2025-03-31 | Cons. | Operating income |
| Operating income | ¥5.5bn | 2023-04-01 → 2024-03-31 | Cons. | Operating income |
| Ordinary income | ¥6.7bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥5.6bn | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥6.7bn | 2022-04-01 → 2023-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥6.3bn | 2021-04-01 → 2022-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥6.1bn | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥6.5bn | 2024-04-01 → 2025-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥4.1bn | 2023-04-01 → 2024-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥4.0bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.3bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥3.2bn | 2022-04-01 → 2023-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥3.5bn | 2021-04-01 → 2022-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥3.5bn | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥4.0bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss |
| Net income | ¥2.3bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss |
| Total assets | ¥70.1bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥75.2bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥69.9bn | at 2023-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥70.7bn | at 2022-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥60.1bn | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥47.4bn | at 2025-03-31 | Cons. | Liabilities |
| Total liabilities | ¥54.7bn | at 2024-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥22.7bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥20.5bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥21.6bn | at 2023-03-31d | Cons. | Net assets |
| Net assets / equity | ¥20.1bn | at 2022-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥18.5bn | at 2021-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥14.0bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥15.1bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥14.0bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥15.1bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥11.9bn | at 2023-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥10.2bn | at 2022-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥9.0bn | at 2021-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥5.9bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥7.9bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥9.0bn | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥5.5bn | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥6.7bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | ¥347m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.8bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.2bn | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥7.4bn | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥3.8bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥7.3bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥1.8bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥5.2bn | 2022-04-01 → 2023-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥3.2bn | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥5.7bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥42.94 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥24.11 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥33.53 | 2022-04-01 → 2023-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥37.08 | 2021-04-01 → 2022-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥37.51 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥24.11 | 2023-04-01 → 2024-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥33.53 | 2022-04-01 → 2023-03-31d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥37.02 | 2021-04-01 → 2022-03-31d | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥37.41 | 2020-04-01 → 2021-03-31d | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥245.81 | at 2025-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥222.07 | at 2024-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥227.83 | at 2023-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥212.96 | at 2022-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥195.51 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 32.4% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 27.2% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 30.9% | at 2023-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 28.5% | at 2022-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 30.7% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 18.4% | 2024-04-01 → 2025-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 10.7% | 2023-04-01 → 2024-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 15.2% | 2022-04-01 → 2023-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 18.1% | 2021-04-01 → 2022-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 20.1% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 33,616 | at 2025-03-31 | Cons. | Number of employees |
| Employees | 33,884 | at 2024-03-31 | Cons. | Number of employees |
| Employees | 31,982 | at 2023-03-31d | Cons. | Number of employees |
| Employees | 30,928 | at 2022-03-31d | Cons. | Number of employees |
| Employees | 29,838 | at 2021-03-31d | Cons. | Number of employees |
| Revenue | ¥109.6bn | 2024-04-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥105.5bn | 2023-04-01 → 2024-03-31 | Standalone | Net sales |
| Revenue | ¥106.1bn | 2022-04-01 → 2023-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥91.7bn | 2021-04-01 → 2022-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥82.3bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥5.1bn | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Operating income | ¥3.5bn | 2023-04-01 → 2024-03-31 | Standalone | Operating income |
| Ordinary income | ¥4.9bn | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥3.6bn | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥4.8bn | 2022-04-01 → 2023-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥4.8bn | 2021-04-01 → 2022-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥4.7bn | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥4.7bn | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Profit before tax | −¥499m | 2023-04-01 → 2024-03-31 | Standalone | Income before income taxes |
| Net income | ¥3.3bn | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | −¥1.3bn | 2023-04-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | ¥3.3bn | 2022-04-01 → 2023-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥2.9bn | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥2.9bn | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥65.6bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥68.3bn | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥67.9bn | at 2023-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥61.6bn | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥52.0bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥49.0bn | at 2025-03-31 | Standalone | Liabilities |
| Total liabilities | ¥53.2bn | at 2024-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥16.5bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥15.1bn | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥19.7bn | at 2023-03-31d | Standalone | Net assets |
| Net assets / equity | ¥18.3bn | at 2022-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥17.2bn | at 2021-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥11.9bn | at 2025-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥11.9bn | at 2024-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥35.47 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-14.11 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥34.92 | 2022-04-01 → 2023-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥30.25 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥30.69 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥34.91 | 2022-04-01 → 2023-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥30.2 | 2021-04-01 → 2022-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥30.62 | 2020-04-01 → 2021-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥20 | 2024-04-01 → 2025-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥20 | 2023-04-01 → 2024-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥20 | 2022-04-01 → 2023-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥20 | 2021-04-01 → 2022-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥19.5 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥179.17 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥163.3 | at 2024-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥208.55 | at 2023-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥192.9 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥182.17 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 25.2% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 22.1% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 29.1% | at 2023-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 29.6% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.1% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 20.7% | 2024-04-01 → 2025-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | -7.6% | 2023-04-01 → 2024-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 17.4% | 2022-04-01 → 2023-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 16.1% | 2021-04-01 → 2022-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 17.4% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 94,741,793 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 94,741,793 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 94,653,362 | at 2023-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 94,579,550 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 94,437,900 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 28,041 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 27,802 | at 2024-03-31 | Standalone | Number of employees |
| Employees | 26,880 | at 2023-03-31d | Standalone | Number of employees |
| Employees | 24,890 | at 2022-03-31d | Standalone | Number of employees |
| Employees | 24,286 | at 2021-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 82
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | capex | 2024-04-01 → 2025-03-31 | ¥0 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2024-04-01 → 2025-03-31 | ¥7m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2025-03-31 | 34 pure |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-04-01 → 2025-03-31 | ¥279m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-04-01 → 2025-03-31 | ¥279m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2025-03-31 | ¥71m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-04-01 → 2025-03-31 | −¥20m |
| Reconciling Itemsreconciling | segment assets | at 2025-03-31 | ¥13.3bn |
| Children Businessreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥94m |
| Children Businessreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥193m |
| Children Businessreportable segment | employees | at 2025-03-31 | 1505 pure |
| Children Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥10.8bn |
| Children Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥10.8bn |
| Children Businessreportable segment | segment assets | at 2025-03-31 | ¥9.5bn |
| Children Businessreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥401m |
| Elderly Care Businessreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥588m |
| Elderly Care Businessreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥889m |
| Elderly Care Businessreportable segment | employees | at 2025-03-31 | 9370 pure |
| Elderly Care Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥55.3bn |
| Elderly Care Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥55.3bn |
| Elderly Care Businessreportable segment | segment assets | at 2025-03-31 | ¥36.9bn |
| Elderly Care Businessreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥2.2bn |
| Medical Businessreportable segment | capex | 2024-04-01 → 2025-03-31 | ¥447m |
| Medical Businessreportable segment | depreciation | 2024-04-01 → 2025-03-31 | ¥361m |
| Medical Businessreportable segment | employees | at 2025-03-31 | 22488 pure |
| Medical Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥71.0bn |
| Medical Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥71.0bn |
| Medical Businessreportable segment | segment assets | at 2025-03-31 | ¥10.4bn |
| Medical Businessreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥4.4bn |
| —segment total | capex | 2024-04-01 → 2025-03-31 | ¥1.1bn |
| —segment total | depreciation | 2024-04-01 → 2025-03-31 | ¥1.4bn |
| —segment total | revenue | 2024-04-01 → 2025-03-31 | ¥137.2bn |
| —segment total | revenue external | 2024-04-01 → 2025-03-31 | ¥137.2bn |
| —segment total | segment assets | at 2025-03-31 | ¥56.7bn |
| —segment total | segment profit | 2024-04-01 → 2025-03-31 | ¥7.0bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2024-04-01 → 2025-03-31 | ¥1.1bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2024-04-01 → 2025-03-31 | ¥1.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2025-03-31 | ¥137.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2025-03-31 | ¥137.4bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2025-03-31 | ¥56.8bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2025-03-31 | ¥7.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | capex | 2023-04-01 → 2024-03-31 | ¥28m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2023-04-01 → 2024-03-31 | ¥11m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-04-01 → 2024-03-31 | ¥236m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-04-01 → 2024-03-31 | ¥236m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2024-03-31 | ¥83m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-04-01 → 2024-03-31 | −¥575m |
| Reconciling Itemsreconciling | segment assets | at 2024-03-31 | ¥14.2bn |
| Children Businessreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥45m |
| Children Businessreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥192m |
| Children Businessreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥10.2bn |
| Children Businessreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥10.2bn |
| Children Businessreportable segment | segment assets | at 2024-03-31 | ¥10.1bn |
| Children Businessreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥307m |
| Elderly Care Businessreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥7.2bn |
| Elderly Care Businessreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥966m |
| Elderly Care Businessreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥53.9bn |
| Elderly Care Businessreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥53.9bn |
| Elderly Care Businessreportable segment | segment assets | at 2024-03-31 | ¥40.5bn |
| Elderly Care Businessreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥1.5bn |
| Medical Businessreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥529m |
| Medical Businessreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥344m |
| Medical Businessreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥70.8bn |
| Medical Businessreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥70.8bn |
| Medical Businessreportable segment | segment assets | at 2024-03-31 | ¥10.3bn |
| Medical Businessreportable segment | segment profit | 2023-04-01 → 2024-03-31 | ¥4.3bn |
| —segment total | capex | 2023-04-01 → 2024-03-31 | ¥7.7bn |
| —segment total | depreciation | 2023-04-01 → 2024-03-31 | ¥1.5bn |
| —segment total | revenue | 2023-04-01 → 2024-03-31 | ¥134.9bn |
| —segment total | revenue external | 2023-04-01 → 2024-03-31 | ¥134.9bn |
| —segment total | segment assets | at 2024-03-31 | ¥60.9bn |
| —segment total | segment profit | 2023-04-01 → 2024-03-31 | ¥6.1bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2023-04-01 → 2024-03-31 | ¥7.8bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2023-04-01 → 2024-03-31 | ¥1.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2024-03-31 | ¥135.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2024-03-31 | ¥135.1bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2024-03-31 | ¥61.0bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2024-03-31 | ¥5.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2025-03-31 | 34 pure |
| Children Businessreportable segment | employees | at 2025-03-31 | 886 pure |
| Elderly Care Businessreportable segment | employees | at 2025-03-31 | 4417 pure |
| Medical Businessreportable segment | employees | at 2025-03-31 | 22485 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,654
| Item | Context | Value | Unit |
|---|---|---|---|
| Footnotes directors and corporate auditors proposal (text) | FilingDateInstant_Row10Member | Text · Plus | |
| Footnotes directors and corporate auditors proposal (text) | FilingDateInstant_Row11Member | Text · Plus | |
| Outside directors and outside corporate auditors (text) | FilingDateInstant | Text · Plus | |
| Audits (text) | FilingDateInstant | Text · Plus | |
| Remuneration for directors and other officers (text) | FilingDateInstant | Text · Plus | |
| Shareholdings (text) | FilingDateInstant | Text · Plus | |
| Regulations in accordance with which consolidated financial statements have been prepared financial information | CurrentYearDuration | Text · Plus | |
| Regulations in accordance with which financial statements have been prepared financial information | CurrentYearDuration | Text · Plus | |
| Description of fact that financial statements have been prepared in accordance with special provision financial information | CurrentYearDuration | Original text (Japanese)また、当社は、特例財務諸表提出会社に該当し、財務諸表等規則第127条の規定により財務諸表を作成しています。 | |
| Note on independent audit financial information | CurrentYearDuration | Text · Plus | |
| Remarkable efforts to ensure fair presentation of consolidated financial statements etc financial information | CurrentYearDuration | Text · Plus | |
| Consolidated balance sheet (text) | CurrentYearDuration | Text · Plus | |
| Consolidated statement of income (text) | CurrentYearDuration | Text · Plus | |
| Consolidated statement of comprehensive income (text) | CurrentYearDuration | Text · Plus | |
| Consolidated statement of changes in equity (text) | CurrentYearDuration | Text · Plus | |
| Consolidated statement of cash flows (text) | CurrentYearDuration | Text · Plus | |
| Notes significant accounting policies for preparation of consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Number of consolidated subsidiaries and names of major consolidated subsidiaries (text) | CurrentYearDuration | Text · Plus | |
| Changes in scope of consolidation (text) | CurrentYearDuration | Text · Plus | |
| Names of major unconsolidated subsidiaries and reasons for exclusion from scope of consolidation (text) | CurrentYearDuration | Text · Plus | |
| Number of unconsolidated subsidiaries and associates accounted for using equity method and names of major entities accounted for using equity method (text) | CurrentYearDuration | Text · Plus | |
| Names of major unconsolidated subsidiaries and associates and reasons for not being accounted for using equity method (text) | CurrentYearDuration | Text · Plus | |
| Disclosure about fiscal years etc of consolidated subsidiaries (text) | CurrentYearDuration | Text · Plus | |
| Disclosure of accounting policies (text) | CurrentYearDuration | Text · Plus | |
| Significant accounting estimates consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes changes in accounting policies in accordance with changes in accounting standards etc consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes new accounting standards not yet applied consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding accumulated depreciation of property plant and equipment (text) | CurrentYearInstant | Text · Plus | |
| Notes regarding shares and bonds etc of unconsolidated subsidiaries and associates (text) | CurrentYearInstant | Text · Plus | |
| Notes regarding amounts of reduction entry of property plant and equipment (text) | CurrentYearInstant | Text · Plus | |
| Debtors notes regarding overdraft contracts and or loan commitments (text) | CurrentYearInstant | Text · Plus | |
| Notes regarding amount of revenue from contracts with customers (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding cost of sales (text) | CurrentYearDuration | Text · Plus | |
| Major components of selling general and administrative expenses (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding impairment loss (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding payments for employment of persons with disabilities (text) | CurrentYearDuration | Text · Plus | |
| Notes business restructuring expenses (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding reclassification adjustments income taxes and tax effects relating to other comprehensive income (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding issued shares and treasury shares (text) | Prior1YearDuration | Text · Plus | |
| Notes regarding new share subscription rights etc (text) | Prior1YearDuration | Text · Plus | |
| Notes regarding dividend (text) | Prior1YearDuration | Text · Plus | |
| Notes regarding issued shares and treasury shares (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding new share subscription rights etc (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding dividend (text) | CurrentYearDuration | Text · Plus | |
| Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text) | CurrentYearDuration | Text · Plus | |
| Major components of assets and liabilities of consolidated subsidiary acquired by purchase of shares during reporting period (text) | CurrentYearDuration | Text · Plus | |
| Major components of assets and liabilities increased or decreased as result of acquisition or disposal of business or merger etc whereby cash was paid or received as consideration (text) | CurrentYearDuration | Text · Plus | |
| Notes leases consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes financial instruments consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes securities consolidated financial statements (text) | CurrentYearDuration | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |